weight loss, drugs

Eli Lilly forecast sales of popular weight-loss drug Zepbound and related diabetes treatment Mounjaro to miss Wall Street ...
Retatrutide, an experimental drug by Eli Lilly, shows promising results in weight loss by targeting three hormones, ...
We meet some of the first NHS patients, as expert says funding everyone eligible would "bankrupt" the service.
Eli Lilly's experimental weight loss drug, retatrutide, has demonstrated encouraging results in helping obese adults lose weight.
Eli Lilly said on Monday it has sued two medical spas for selling unapproved products claiming to contain tirzepatide, the ...
A new trend gaining popularity among people trying to lose weight is microdosing the diabetes medication Ozempic. With ...
Zepbound is a dual-activating medication that combines glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like ...
There’s still scope for a new generation of drugs to replace weight-loss market leaders like Novo Nordisk A/S’s Wegovy, ...